BRIEF-Lilly CEO says prepared for all scenarios in case of ACA repeal

* Lilly CEO says if all Alimta patents are upheld, drug will be exclusively marketed in the U.S. till 2022 [Source]

Publication Date: Tuesday, 31 January 2017 at 20:09:01

Origin: reuters.com

Category: rbssHealthcareNews

Topics: marketed, exclusively, will be, upheld, patents, Alimta, Lilly, repeal, scenarios, prepared, BRIEF-Lilly

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/QLSJuS5-sYY/idUSFWN1FL0TR

Related Articles

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22